82 related articles for article (PubMed ID: 6291223)
1. [Extraction and freeze-drying of herpes virus C3-1 isolated from turkeys].
Kasabov R; Nikiforova M
Vet Med Nauki; 1982; 19(3):10-5. PubMed ID: 6291223
[TBL] [Abstract][Full Text] [Related]
2. Trials with Marek's disease vaccines prepared from a turkey herpes virus and an attenuated Marek's disease virus.
Blaxland JD; Macleod AJ; Hall T
Vet Rec; 1975 Jul; 97(3):50-2. PubMed ID: 168681
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the prophylactic efficacy of lyophilized and cell-associated turkey herpesvirus against Marek's disease.
Kilgore RL
Avian Dis; 1974; 18(1):45-9. PubMed ID: 4205347
[No Abstract] [Full Text] [Related]
4. Marek's disease vaccine: prophylactic efficacy of a lyophilized turkey herpesvirus of chick cell-culture origin.
Kilgore RL; Brokken ES
Avian Dis; 1973; 17(1):137-41. PubMed ID: 4633273
[No Abstract] [Full Text] [Related]
5. An improved method for extracting cell-free herpesviruses of Marek's disease and turkeys from infected cell cultures.
Cho BR
Avian Dis; 1978; 22(1):170-6. PubMed ID: 206250
[TBL] [Abstract][Full Text] [Related]
6. Partial inhibition by turkey herpesvirus of serotype 2 Marek's disease virus plaque formation and in vivo infectivity.
Witter RL; Bacon LD; Calvert JG
Avian Dis; 1994; 38(4):800-9. PubMed ID: 7702514
[TBL] [Abstract][Full Text] [Related]
7. A recombinant fowlpox virus vaccine expressing glycoprotein B gene from CVI988/Rispens strain of MDV: protection studies in different chickens.
Liu X; Peng D; Wu X; Xing L; Zhang R
Acta Virol; 1999; 43(2-3):201-4. PubMed ID: 10696446
[TBL] [Abstract][Full Text] [Related]
8. Infectivity of Marek's disease agent after different treatments used in vaccine production.
Kottaridis SD; Luginbuhl RE; Fredrickson TN
Am J Vet Res; 1969 Oct; 30(10):1851-5. PubMed ID: 10200110
[No Abstract] [Full Text] [Related]
9. Embryo vaccination against Marek's disease with serotypes 1, 2 and 3 vaccines administered singly or in combination.
Sharma JM; Witter RL
Avian Dis; 1983; 27(2):453-63. PubMed ID: 6307248
[TBL] [Abstract][Full Text] [Related]
10. [Results of a comparative field research study using deep freeze and lyophilized turkey herpes virus vaccine as protection against Marek's disease].
Dangschat H; Rapp W; Bengelsdorff HJ
Berl Munch Tierarztl Wochenschr; 1973 Dec; 86(23):450-3. PubMed ID: 4772612
[No Abstract] [Full Text] [Related]
11. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
[TBL] [Abstract][Full Text] [Related]
12. Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease.
Calnek BW; Schat KA; Peckham MC; Fabricant J
Avian Dis; 1983; 27(3):844-9. PubMed ID: 6314982
[TBL] [Abstract][Full Text] [Related]
13. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus.
Nazerian K; Witter RL; Lee LF; Yanagida N
Avian Dis; 1996; 40(2):368-76. PubMed ID: 8790888
[TBL] [Abstract][Full Text] [Related]
14. Marek's disease tumors in chickens vaccinated with turkey herpesvirus vaccine.
Eidson CS
Dev Biol Stand; 1982; 52():437-46. PubMed ID: 7166202
[TBL] [Abstract][Full Text] [Related]
15. Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell-free Marek's disease vaccine.
Sharma JM; Graham CK
Avian Dis; 1982; 26(4):860-70. PubMed ID: 6297450
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with lyophilized turkey herpesvirus (HVT): minimum infective and protective doses.
Patrascu IV; Calnek BW; Smith MW
Avian Dis; 1972 Apr; 16(1):86-93. PubMed ID: 4623703
[No Abstract] [Full Text] [Related]
17. Derivation, safety and efficacy of a Marek's disease vaccine developed from an Australian isolate of very virulent Marek's disease virus.
Karpathy RC; Firth GA; Tannock GA
Aust Vet J; 2002; 80(1-2):61-6. PubMed ID: 12180882
[TBL] [Abstract][Full Text] [Related]
18. Early posthatch protection against Marek's disease in chickens vaccinated in ovo with a CVI988 serotype 1 vaccine.
Zhang Y; Sharma JM
Avian Dis; 2001; 45(3):639-45. PubMed ID: 11569737
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a combination vaccine containing MDV CVI 988 strain and HVT against challenge with very virulent MDV.
Geerligs HJ; Weststrate MW; Pertile TL; Rodenberg J; Kumar M; Chu S
Acta Virol; 1999; 43(2-3):198-200. PubMed ID: 10696445
[TBL] [Abstract][Full Text] [Related]
20. [Method of titration of lyophilized and cell-associated Marek-vaccines].
Kraft V; Ingwersen P; Monreal G
Berl Munch Tierarztl Wochenschr; 1973 Aug; 86(15):283-5. PubMed ID: 4754184
[No Abstract] [Full Text] [Related]
[Next] [New Search]
